Angiographic morphology in unstable angina and its relation to transient myocardial ischemia and hospital outcome☆
References (18)
- et al.
Unstable angina pectoris: National Cooperative Study Group to compare medical and surgical therapy. II. In-hospital experience and initial follow-up in patients with one, two and three vessel disease
Am J Cardiol
(1978) - et al.
Angiographic morphology and pathogenesis of unstable angina pectoris
J Am Coll Cardiol
(1985) - et al.
Angiographic morphology in unstable angina pectoris
Am J Cardiol
(1988) - et al.
Use of percutaneous transluminal coronary angioplasty and bypass surgery despite improved medical therapy for unstable angina pectoris
Am J Cardiol
(1988) - et al.
Prognostic significance of silent myocardial ischemia in patients with unstable angina
J Am Coll Cardiol
(1987) - et al.
ST segment shift in unstable angina: pathophysiology and association with coronary anatomy and hospital outcome
J Am Coll Cardiol
(1989) - et al.
Prognosis in unstable angina
Br Heart J
(1976) - et al.
Coronary angioscopy in patients with unstable angina pectoris
N Engl J Med
(1986) - et al.
Coronary dissection and total coronary occlusion associated with percutaneous transluminal coronary angioplasty: significance of initial angiographic morphology of coronary stenoses
Circulation
(1986)
Cited by (71)
2012 ACCF/AHA focused update incorporated into the ACCF/AHA 2007 guidelines for the management of patients with unstable angina/Non-ST-Elevation myocardial infarction: A report of the american college of cardiology Foundation/American Heart Association task force on practice guidelines
2013, Journal of the American College of CardiologyCitation Excerpt :Complex plaques are usually believed to be responsible for the culprit lesions. These usually are eccentric and sometimes have irregular borders and correlate with intracoronary thrombi and an increased risk of recurrent ischemia at rest, MI, and cardiac death (652). Similar findings were noted in more than 80% of the patients in the VANQWISH trial, and more than 1 complex lesion was found in most patients (621).
2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines
2011, Journal of the American College of CardiologyCitation Excerpt :Complex plaques are usually believed to be responsible for the culprit lesions. These usually are eccentric and sometimes have irregular borders and correlate with intracoronary thrombi and an increased risk of recurrent ischemia at rest, MI, and cardiac death (563). Similar findings were noted in more than 80% of the patients in the VANQWISH trial, and more than 1 complex lesion was found in most patients (534).
Recurrent ischemia after reperfusion therapy for acute myocardial infarction
2010, Cardiac Intensive Care: Expert ConsultRecurrent Ischemia after Reperfusion Therapy for Acute Myocardial Infarction
2010, Cardiac Intensive CareContinuous ST-Segment Monitoring in Contemporary Acute Coronary Syndrome Patients. The Magic of MERLIN-TIMI 36
2009, Journal of the American College of CardiologyAssociation of plasma leptin levels and complexity of the culprit lesion in patients with unstable angina
2008, International Journal of CardiologyCitation Excerpt :Clinical studies have shown the presence of these angiographically visible complex lesions as having a multitude of adverse outcomes, with the possibility that these types of lesions might predict myocardial infarction [12]. The presence of complex lesions is also seen to be associated with a higher incidence of in-hospital cardiac events [13,14] and also they were found to be associated with higher complication rates following angioplasty in patients with UA [15]. Leptin is a 16-kDa peptide hormone that plays a central role in the regulation of body weight.
- ☆
This study was supported in part by a 1989 research Grant 8834260 from the C.N.R. (Consiglio Nazionale Delle Ricerche), Rome, Italy.